Fairmount Funds Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.4M | Buy |
2,707,191
+6,500
| +0.2% | +$121K | 6.53% | 7 |
|
|
2025
Q1 | $49M | Hold |
2,700,691
| – | – | 7.6% | 6 |
|
|
2024
Q4 | $58.9M | Hold |
2,700,691
| – | – | 5.85% | 9 |
|
|
2024
Q3 | $73.9M | Sell |
2,700,691
-62,146
| -2% | -$1.7M | 6% | 9 |
|
|
2024
Q2 | $71.5M | Hold |
2,762,837
| – | – | 8.08% | 6 |
|
|
2024
Q1 | $82.9M | Buy |
2,762,837
+834,334
| +43% | +$25M | 9.03% | 4 |
|
|
2023
Q4 | $20.1M | Hold |
1,928,503
| – | – | 2.12% | 12 |
|
|
2023
Q3 | $26.4M | Buy |
+1,928,503
| New | +$26.4M | 3.17% | 13 |
|